Clinical Decision-MakingPatient Care Practicesbody weightHP1cGLP1
Benefits of GLP-1 agonist Medicines in Diabetes.
Dr Sheharyar Quraishi, Consultant Endocrinologist and Diabetologist talks about things to look out for if you are started on GLP-1 inhibitors. He explains how GLP-1 inhibitors should improve HbA1c levels as well as body weight. These things should improve after six months of treatment.
Transcript (auto-generated)
This transcript was generated automatically and may contain errors.
Okay, the NICE would recommend that we look out for a reduction in the HP1c and also a reduction in the body weight. And these are the two parameters that use at six month interval or the time span to consider whether the treatment with GLP1 should be continued or discontinued. Then the continuation recommends that patients should have at least one percent change in the HP1c after six months and a three percent change in the body weight to be considered to continue GLP1 therapy.
Health Shared
Comments